Russia registers nasal version of Sputnik V
Alexander Gintsburg, Director of the Gamaleya Center, had earlier told the agency that it will be efficient against the new Omicron coronavirus strain.
Alexander Gintsburg, Director of the Gamaleya Center, had earlier told the agency that it will be efficient against the new Omicron coronavirus strain.
The Sputnik V vaccine has demonstrated strong protection against Omicron variant, with over 2 times higher virus neutralising activity compared…
The meeting between Mansukh Mandaviya and Dr. Satish Reddy was held to discuss the Sputnik V vaccine production and its supply.
The officials also informed that the SII has already received cell and vector samples from the Gamaleya Center as part of the technology transfer process.
The Russian Direct Investment Fund (RDIF) and Serum Institute of India (SII), intend to produce over 300 million doses of the vaccine in India, per year.
With this initiative, the Gurugram district will be among the first ones across Haryana, where the Russian-made vaccine will be administered at government facilities.
The first batch of the vaccine will be shipped to Russia's Gamaleya Center for quality control.
An Indraprastha Apollo hospital official told IANS on Sunday that Sputnik V was yet to be rolled out, but "the management is working on it".
As per the sources, Dr Reddy's, which is authorised to distribute the Russian Covid-19 jabs to different hospitals, have not supplied enough doses to the hospitals.
Anvisa had approved the import and emergency use of Sputnik V with many restrictions
